Modifications
A large number of immunoassays exist that are based on a variety of methodologies [for review see (l-4) ]. Many assays have been developed for quantitation of specific soluble molecules of interest, but only a few assays have been designed to provide systems useful for quantitation of membrane antigens (56). These assays have not been sufficiently characterized for reliable quantitation of membrane antigens in different subcellular fractions. The objective of the work reported here was to develop an immunoassay for quantitation of integral membrane antigens in complex mixtures during subcellular fractionation. The assay is currently being used to develop methods to subfractionate pancreatic acinar cell plasma membranes into apical and basolat-era1 fractions. A variation of the assay is also being used to screen for hybridomas producing monoclonal antibodies to membrane antigens.
MATERIALS AND METHODS
Reagents. Sheep anti-rat Ig-@-galactosidase was obtained from Amersham (Naperville, IL). Nitrocellulose paper (0.45-pm pore size) was obtained from Bio-Rad (Richmond, CA). All other chemicals were obtained from Sigma Chemical (St. Louis, MO).
Subcellular fractionation of mouse pancreas. Plasma membranes were prepared from mouse pancreas using an adaptation of an established technique (7, 8) . All steps were performed at 4°C. Mouse pancreatic tissue was minced with scissors and suspended in 1 mM NaHCO,, pH 7.4,0.5 mM MgCl,, 0.1 mM phenylmethylsulfonyl fluoride, and 1 mM benzamidine at 1 g tissue/5 ml buffer. The suspension was homogenized for 30 s at setting 5 with a Brinkman homogenizer (Brinkman Instruments, Westbury, NY), followed by three strokes with a glass-Teflon homogenizer at 1300 rpm. The homogenate was centrifuged to pellet unbroken cells by accelerating the centrifuge to 1300g and then stopping immediately. The pellet was rehomogenized and pelleted as above and the two supernatants were combined. The combined supernatants were considered as the homogenate which was then diluted 20-fold in the same buffer without MgCl, and plus 0.7 mM EDTA, and incubated on ice for 10 min. The homogenate was filtered through four layers of gauze and was centrifuged at 1300g for 15 min to pellet large membrane sheets. The upper surface of this pellet (the "fluffy" layer) was rinsed off with homogenization buffer and the remaining pellet was considered as the crude plasma membrane fraction. The crude plasma membranes were resuspended in 46% sucrose (w/v) in a Dounce homogenizer with a tight pestle (pestle A), placed into 1 SW 41 centrifuge tubes, overlaid with 10% sucrose, and centrifuged for 2 h at 38,000 rpm. The purified plasma membranes were removed from the interface, washed in phosphate-buffered saline (PBS;' 20 mM PO,, 150 mM NaCl, pH 7.4) by ultracentrifugation, resuspended in PBS at -1 mg protein per ml, and stored at -70°C. h4onoclonaZ antibodies.
The monoclonal antibodies used were produced by fusion of the mouse myeloma SP2/0-Ag14 with rat spleen cells by conventional methods (9). Acinar-1, one of the monoclonal antibodies (mAb) used in this study, has been described previously (8) and was raised against a primary monolayer culture of mouse acinar cells. The other mAb used in the current study, 4.1B12, was obtained by immunizing rats with 1% Triton X-100 solubilized plasma membranes prepared as above. The characteristics of the mAbs are described under Results.
Standard dot-blot immunoassay protocol.
Samples for assay were suspended at 4°C in Tris-buffered saline (TBS; 10 mM Tris, pH 7.0, 150 mM NaCl) at protein concentrations of 0.1 mg/ml and disrupted by sonication on ice with a probe-type sonicator (Branson Ultrasonics Corp., Danbury, CT) for 5 s at a 60-W output. Serial twofold dilutions were made in TBS and applied to 0.45-pm pore size nitrocellulose in a commercial dotblot apparatus (Bio-Rad).
The apparatus was then disassembled and the nitrocellulose was placed in 10 ml of blocking solution (3% bovine serum albumin, 0.05% Tween-20, in PBS) and incubated with gentle agitation for 2 h at room temperature.
After blocking, 10 ml of mAb-containing spent hybridoma culture supernatant (10% fetal bovine serum in RPMI-1640 medium) was added to the blocking solution and incubated overnight at 4°C with gentle agitation.
The nitrocellulose was then washed 4 X 10 min with 25 ml of 0.05% Tween-20 in PBS. Next, the nitrocellulose was incubated with 10 ml of sheep anti-rat P-galactosidase-coupled second antibody diluted 1:1250 in blocking solution for 2 h at room temperature with agitation and then washed again as above. For the enzymatic readout, the individual samples were punched out from the nitrocellulose with an eight-channel punch of 6 mm diameter (designed and built in the Physiology Department Machine Shop) and transferred to wells of a 96-well plate. Sample blanks were obtained by punching out areas of the nitrocellulose between the wells used for samples. A loo-p1 sample of substrate solution (3 mM o-nitrophenyl galactopyranoside (oNPG), 10 mM 2-mercaptoethanol, 10 mM MgSO,, in PBS) was added, and the samples were incubated until sufficient color developed, usually 0.5-2 h at room temperature.
The reaction was stopped with 50 ~1 of 1 M Na,CO,, and the reaction product was transferred to a clean 96-well plate. The OD,, nm was read using a multiwell plate reader (Flow Labs, McLean, VA), which was zeroed using the reaction product from sample blanks prepared as described above.
Variation of the assay to screen for hybridomas producing mAb against membrane proteins.
A variation of the assay was made which allows testing of large numbers of hybridoma culture supernatants as a screening procedure for mAb against membrane fractions. The same amount of membrane protein was applied to each well in the dot-blot apparatus and the samples were punched-out and placed in 96 well plates. All the incubations were then carried out in the 96-well plates, allowing different primary mAbs to be used for each sample. With this method, it was possible to screen -2000 wells for membrane antigen-specific mAb production in a single run covering 2 days time.
Data analysis.
The immunoassay was designed to be a pseudo-first-order reaction (see Results) such that the signal would be linearly related to the amount of antigen in the sample. The data were analyzed by linear regression of the OD4,,5nm vs micrograms of sample and the slopes of these lines were taken as the specific activities of the antigen in the samples. Regression coefficients usually exceeded 0.9.
Immunoblots
of Western-transferred protein. 4.1B12, is also a rat IgG,, which recognizes a 32-kDa protein of mouse pancreatic acinar cells. A Western blot shown in Fig. 1 demonstrates the molecular weight determination for these antigens using isolated pancreatic plasma membranes.
By indirect immunofluorescence (not shown) and electron microscopic immunoperoxidase labeling (Fig. 2) , 4.1B12 labels the basal and lateral membrane domains of acinar cells with no detectable labeling of the apical membrane domain. The membrane proteins studied in this work were integral membrane proteins, as determined by the inability of 0.1 M Na,CO, to solubilize them (not shown).
Design of the immunoassay. Initial attempts were made to use a solid-phase enzymatic immunoassay whose end product was an insoluble deposit on nitrocellulose paper (13, 14) . This approach did not work well to quantitate antigens in various membrane fractions. The major problem was uneven development of reaction product on the nitrocellulose which made quantitation by reflectance densitometry unreliable. This may have been due to the particulate nature of the samples (membrane sheets and vesicles) and uneven deposition on the nitrocellulose. Therefore, the assay was adapted to produce a soluble end product which could be reliably quantitated by absorption spectrophotometry. The assay was designed to obtain a pseudo-first-order relationship between the amount of antigen applied and the signal observed. To achieve this, the amount of antigen was limiting and all other reagents were applied at saturating levels. Therefore, the form of the data assumes a linear relationship between antigen and signal and is easily analyzed by linear regression to obtain a slope, which gives a specific activity value for the antigen content of the sample.
Color development. Details of the assay are given under Materials and Methods. Up until the final step, color development, the nitrocellulose remained as a sin- gle piece which made all the necessary handling in the preceding steps easy and rapid. Now, the individual spots containing the samples were punched out so that they could be separately incubated with the chromogenic substrate, oNPG, in 96-well plates.
Linearity of the reaction.
A typical assay result is shown in Fig. 3 using the basolateral mAb 4.1B12 and the different fractions obtained during membrane preparation. The signal was linearly related to the amount of sample up to the point where the amount of antigen is no longer the limiting factor. The capacity of the nitrocellulose for protein binding is estimated to be 80 pg/ cm2 (15), which corresponds to 25 pg10.32 cm2 sample well, so samples of low antigen content relative to total protein can be assayed. The linear correlation coefficients for the data in Fig. 3 were 0.999 for the homogenate, 0.984 for the supernatant, 0.995 for the fluffy layer, 0.996 for the crude plasma membrane fraction, and 0.998 for the final plasma membrane fraction. The enrichments, compared to the homogenate, of 4.1B12 immunoreactivity (basolateral marker), K+-stimulated pNPPase activity (basolateral marker, [16] ), and acinar-1 immunoreactivity (apical marker) are shown in Table 1 . Note that the enrichments of 4.1B12 immunoreactivity and K+-stimulated pNPPase activity parallel each other, as is expected since both are localized to the basolateral plasma membrane. The final plasma membrane fraction was enriched -2O-fold for both basolatera1 markers. In addition, the final plasma membrane fraction was enriched about 4-fold in the apical marker, Acinar-1 immunoreactivity, compared to the homogenate. Thus, plasma membranes prepared as described contain both basolateral and apical membrane domains.
Quantitative recovery of immunoreactivities.
Other assays for quantitating membrane antigens have been described (5, 6) . In determining whether those assays were quantitative, the authors demonstrated that the signal obtained was proportional to the amount antigen in a given sample, as was carried out for the current assay as described above. A more rigorous test of the quantitative nature of an assay and its general applicability is whether overall recoveries of activities in different subcellular fractions are obtained. If this criterion is met, then the assay is of general usefulness to measure antigen content in various samples of complex composition. An overall balance sheet using the different fractions obtained in preparing plasma membranes is shown in Table 1 . The recoveries of immunoreactivities were near 100% for both mAbs, and a little less for the enzyme, which may be somewhat labile. Thus, the assay is quantitative using different subcellular fractions as well as serial dilutions of a single sample.
Conclusions.
The enzymatic dot-blot assay described here is a quantitative immunoassay for integral membrane proteins giving good overall recovery values for different subcellular fractions. This assay is similar to the enzyme-linked immunofiltration assay of IJsselmuiden et al. (17) , except that here the color development step takes place in 96-well plates and does not tie up the filtration device. This allows a greater number of samples to be assayed at one time. The assay described here is also relatively rapid and has the capacity to handle a large number of samples. This assay does not require pure antigen as long as relative activities and enrichments are sufficient. A variation of the assay allows the screening of large numbers of hybridomas for membrane fraction specific mAbs. 
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